1 active not recruiting, 1 completed, 1 terminated, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Long QT syndrome type 3: new trials by email Literature Review of Long QT syndrome type 3 trials Research Report on Long QT syndrome type 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3 Long QT Syndrome Type 3, Long QT Syndrome 2 | Active not recruiting | Thryv Therapeutics, Inc. | 200 | 2025-10-27 | 2026-10-08 | |
| Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A Long QT Syndrome, Brugada Syndrome | Completed | Centre Hospitalier Universitaire de la Réunion | 47 | 2022-04-05 | 2025-08-05 | |
| Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 Eleclazine, Eleclazine placebo - Long QT Syndrome Type 3 | Phase 3 | Terminated | Gilead Sciences | 41 | 2014-12-17 | 2018-01-12 |
| Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine Ranolazine - Long QT Syndrome Type 3 | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 10 | 2012-10-01 | 2015-03-26 |
Long QT Syndrome (3) · Arrhythmias, Cardiac (1) · Brugada Syndrome (1) · Cardiac Conduction System Disease (1) · Death, Sudden, Cardiac (1) · Long Qt Syndrome 2 (1) · Long Qt Syndrome 3 (1)
Cardiovascular Abnormalities (3) · Cardiovascular Diseases (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Heart Defects, Congenital (3) · Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arrhythmias, Cardiac (2) · Cardiac Conduction System Disease (2) · Death (1) · Death, Sudden (1) · Genetic Diseases, Inborn (1) · Heart Arrest (1)
Ranolazine (1) · eleclazine (1)
Centre Hospitalier Universitaire de la Réunion (1) · Gilead Sciences (1) · Tel-Aviv Sourasky Medical Center (1) · Thryv Therapeutics, Inc. (1)
Israel (2) · United States (2) · Canada (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Reunion (1) · United Kingdom (1)
2014 (1)